🇺🇸 FDA
Patent

US 11807868

Adeno-associated variants, formulations and methods for pulmonary delivery

granted A61KA61K9/0078A61K9/12

Quick answer

US patent 11807868 (Adeno-associated variants, formulations and methods for pulmonary delivery) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
4D MOLECULAR THERAPEUTICS INC.
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K9/0078, A61K9/12, A61P, A61P11/00